Damon Runyon Clinical Investigator Award
Damon Runyon Clinical Investigator Award supports independent young physician-scientists conducting disease-oriented research that demonstrates a high level of innovation and creativity. The goal is to support the best young physician-scientists doing work aimed at improving the practice of cancer medicine by providing them with the resources and training structure essential to becoming successful clinical investigators.
$600,000 over three years
- Internal Deadline: January 3, 2020
- Sponsor Deadline (if nominated): February 3, 2020
- Apply within the first five (5) years of their initial full faculty appointment (Cut-off date: July 1, 2015).
- Hold an independent assistant professor position or equivalent.
- Have received an MD, DO, or MD/PhD degree(s) from an accredited institution, completed their subspecialty training and be U.S. Board eligible, and hold a valid, active U.S. medical license at the time of application.
- Be a U.S. citizen or permanent legal resident.
- Cannot hold an R01 at the time of application.
- Commit to spending 80% of their time conducting research.
- Apply in conjunction with a Mentor who is established in the field of clinical translational cancer research, cancer prevention and/or epidemiology and can provide the critical guidance needed during the period of the award.
- No more than two Damon Runyon Clinical Investigators will be funded to work with the same Mentor at any given time.
Address these to be competitive.
- Excellence of the applicant and Mentor.
- Innovation, creativity, quality and originality of the research proposal.
- The commitment of the Mentor and institution to the development and training of the applicant as a skilled clinical research investigator.
- Evidence of the applicant’s commitment to clinical translational and/or cancer prevention research and their ability to apply advances in laboratory research to clinical problems.
- Importance of the proposed research to the field of cancer and/or cancer prevention.
- Adherence of the proposal to the definition of clinical research as set out in guidelines.
- Adherence to the “Handshake Rule.”
Send the following as a single PDF document to Jennifer Kluge at email@example.com (new window)
- 1-page research proposal with a rationale for why you should be nominated and how your proposed research advances your long-term vision and goals in the field of clinical cancer investigation. You should outline your historical, current, and future commitments to clinical/patient research and should consider the aforementioned “Selection Criteria to be Competitive”.
- Abbreviated CV or NIH-style biosketch
For further questions about the sponsor, contact George Kosar, Assistant Vice President, Office of Institutional Partnerships at George.firstname.lastname@example.org (new window).